In addition, examples from other biologic therapies, such as growth factors and gene therapy, that showed early promise but failed clinical translation underscore the importance of rigorous study design, safety monitoring, and realistic expectations in peptide research
Theyre wanting a certain amount of certitude that, frankly, is appropriate for most drugs, but not for this moment. Regulatory shortcuts exist that would allow the FDA to skip the more laborious approval process
That changes the sales format and intended-use presentation, but market availability is not the same as FDA approval or a final legal determination about every aspect of a product
View Article PubChem Chemical structure and property data for BPC 157 (Pentadecapeptide)
For most meniscus tears, non-surgical treatments are offered first
Huberman explains